Daily Journal Names Jason Murray to 2023 “Top Antitrust Lawyers” List
Firm News | 1 min read | 11.30.23
Los Angeles – November 30, 2023: The Daily Journal has named Crowell & Moring partner Jason C. Murray to its 2023 list of “Top Antitrust Lawyers.” The award recognizes California’s “best attorneys that focus on matters such [as] unfair competition and price-fixing.”
Murray is co-chair of the firm's Antitrust & Competition Group and former head of the Los Angeles office. His practice focuses primarily on antitrust litigation for both plaintiffs and defendants; antitrust counseling and defense in connection with state attorneys general, DOJ, and Federal Trade Commission investigations; and business advice on avoiding antitrust risks in transactions, distribution practices, and competitor collaborations. He has handled a wide variety of litigation and antitrust counseling, with a particular emphasis on antitrust cartel litigation and monopolization and exclusive dealing cases for companies in the health care, technology, transportation, entertainment, and telecommunications areas, among others.
The Daily Journal recognized Murray for his work as a health care antitrust lawyer, including in a significant multidistrict litigation involving generic pharmaceutical drugs. The publication also noted Murray’s role on the board of trustees for a Maori trust in his birth country of New Zealand and his work as the chairman of the board of Volunteers of America, Los Angeles.
To read Murray’s full profile, visit here.
Media Contact:
Email: prteam@crowell.com
Insights
Firm News | 1 min read | 03.11.25
Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo
March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn.
Firm News | 2 min read | 03.11.25
Daily Journal Honors Crowell & Moring Victory in University of California Case
Firm News | 2 min read | 03.11.25
Foreign Investment Watch Names Caroline Brown a Top Advisor 2025
Firm News | 2 min read | 03.07.25
Crowell & Moring Attorneys Honored With 2025 Burton Award for Distinguished Legal Writing